Full-Life Technology Europe

Gembloux ·KBO/BCE: BE 0775.415.327

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	03-07-2025	28 d early	2025-00229160
31-12-2023	31-07-2024	02-07-2024	29 d early	2024-00194753
31-12-2022	31-07-2023	17-08-2023	17 d late	2023-00331295

Metric	This company	Sector median	Position in the sector
Solvency	83.0%	46.9%	better than 80% of 46 sector peers
Net result	€-3.20M	€-1k	better than 5% of 46 sector peers
Equity	€34.56M	€108k	better than 95% of 46 sector peers
Gross operating margin	€-4k	€28k	better than 35% of 42 sector peers
Total assets	€41.62M	€284k	better than 91% of 46 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€41.62M
Fixed assets	21/28	€26.65M
Intangible fixed assets	21	€2.70M
Tangible fixed assets	22/27	€23.93M
Financial fixed assets	28	€15k
Current assets	29/58	€14.97M
Amounts receivable within one year	40/41	€13.53M
Cash & bank	54/58	€1.38M
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€41.62M
Equity	10/15	€34.56M
Contributions / capital	10/11	€43.20M
Accumulated profits (losses)	14	€-8.64M
Amounts payable	17/49	€7.07M
Amounts payable within one year	42/48	€7.07M
Trade debts payable within one year	44	€3.56M
Income statement
Gross operating margin	9900	€-4k
Operating result	9901	€-3.10M
Financial income	75	€928
Financial charges	65	€113k
Result before taxes	9903	€-3.25M
Income taxes	67/77	€-47k
Net result for the period	9904	€-3.20M
Result to be appropriated	9905	€-3.20M

Summary

NACE primary	Vervaardiging van geneesmiddelen(21201)
Legal form	Private limited company(610)
Incorporation	06-10-2021
Status	Active
Postal code	5032